| MR编号 | NL/H/0695/003 |
|---|
| 药品名称 | Ciprofloxacine Kabi 100 mg/50 ml, oplossing voor intraveneuze infusie 2 mg/ml |
|---|
| 活性成分 | |
|---|
| 剂型 | Solution for infusion |
|---|
| 上市许可持有人 | Fresenius Kabi Nederland B.V.
Amersfoortseweg 10E
3705 GJ Zeist |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Ciprofloxacin Kabi 400 mg / 200 ml Infusionslösung - Denmark (DK)
- Belgium (BE)
- United Kingdom (Northern Ireland) (XI)
- Austria (AT)
Ciprofloxacin Kabi 400 mg/200 ml Infusionslösung - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Finland (FI)
- Greece (GR)
- Poland (PL)
Ciprofloxacin Kabi - Hungary (HU)
Ciprofloxacin Kabi 400 mg/200 ml - Cyprus (CY)
CIPROFLOXACINE KABI SOLUTION FOR INFUSION 400MG/200ML - Czechia (CZ)
- Slovakia (SK)
Ciprofloxacin Kabi 400 mg/200 ml - Malta (MT)
Ciprofloxacin Kabi 400 mg/200 ml solution for infusion
|
|---|
| 许可日期 | 2007/01/24 |
|---|
| 最近更新日期 | 2024/04/15 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic [Article 10.1.(a)(iii), first paragraph]
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|